TY  - JOUR
AU  - Luetic, Geraldine G
AU  - Menichini, María Laura
AU  - Fernández, Óscar
PY  - 2021
DO  - 10.1016/j.msard.2021.103148
UR  - https://hdl.handle.net/10668/24450
T2  - Multiple sclerosis and related disorders
AB  - Upon the COVID-19 pandemic emergence, safety concerns and logistic drawbacks stimulated the search for alternatives to pulse therapy at infusion centres to treat multiple sclerosis relapses. To describe our experience treating multiple sclerosis...
LA  - en
KW  - COVID-19
KW  - MS
KW  - NMOSD
KW  - Relapse treatment with oral methylprednisolone
KW  - Telemedicine
KW  - Administration, Oral
KW  - COVID-19
KW  - Humans
KW  - Injections, Intravenous
KW  - Methylprednisolone
KW  - Multiple Sclerosis
KW  - Neuromyelitis Optica
KW  - Pandemics
KW  - Powders
KW  - Recurrence
KW  - Retrospective Studies
KW  - SARS-CoV-2
KW  - Water
TI  - Oral administration of methylprednisolone powder for intravenous injection dissolved in water to treat MS and NMOSD relapses during COVID-19 pandemic in a real-world setting.
TY  - research article
VL  - 54
ER  -